As of close of business last night, T2 Biosystems Inc.’s stock clocked out at $0.28, up 3.21% from its previous closing price of $0.27. In other words, the price has increased by $+0.0088 from its previous closing price. On the day, 770256 shares were traded. TTOO stock price reached its highest trading level at $0.2900 during the session, while it also had its lowest trading level at $0.2673.
Top 5 EV Tech Stocks to Buy for 2023
According a new report published by BloombergNEF on investment in the energy transition, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now.
Click Here to Download the FREE Report.
Sponsored
Ratios:
To gain a deeper understanding of TTOO’s stock, we examine its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 1.50 and its Current Ratio is at 1.90.
Upgrades & Downgrades
Insider Transactions:
Investing in insider trades can also provide an investor with insight into how management views future stock prices. A recent insider transaction in this stock occurred on Mar 28 when Gibbs Michael Terrence sold 239 shares for $0.48 per share. The transaction valued at 115 led to the insider holds 6,612 shares of the business.
Sperzel John J III sold 2,898 shares of TTOO for $1,710 on Feb 28. The Chairman and CEO now owns 17,329 shares after completing the transaction at $0.59 per share. On Feb 28, another insider, Gibbs Michael Terrence, who serves as the General Counsel of the company, sold 1,585 shares for $0.59 each. As a result, the insider received 935 and left with 6,517 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, TTOO now has a Market Capitalization of 8.52M and an Enterprise Value of 57.40M. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.26. Its current Enterprise Value per Revenue stands at 2.57 whereas that against EBITDA is -1.07.
Stock Price History:
Over the past 52 weeks, TTOO has reached a high of $15.00, while it has fallen to a 52-week low of $0.26. The 50-Day Moving Average of the stock is 0.3904, while the 200-Day Moving Average is calculated to be 2.2973.
Shares Statistics:
It appears that TTOO traded 628.43K shares on average per day over the past three months and 639.94k shares per day over the past ten days. A total of 20.28M shares are outstanding, with a floating share count of 20.09M. Insiders hold about 0.30% of the company’s shares, while institutions hold 6.80% stake in the company. Shares short for TTOO as of Apr 27, 2023 were 501.47k with a Short Ratio of 0.50M, compared to 570.46k on Mar 30, 2023. Therefore, it implies a Short% of Shares Outstanding of 2.47% and a Short% of Float of 2.49%.
Earnings Estimates
As of right now, 3 analysts gave their recommendation on the stock of the company. On average, analysts expect EPS of -$1.2 for the current quarter, with a high estimate of -$1.1 and a low estimate of -$1.4, while EPS last year was -$5. The consensus estimate for the next quarter is -$0.82, with high estimates of -$0.33 and low estimates of -$1.34.
Analysts are recommending an EPS of between -$1.56 and -$5.19 for the fiscal current year, implying an average EPS of -$2.93. EPS for the following year is -$2.09, with 3 analysts recommending between -$0.69 and -$4.65.
Revenue Estimates
In the current quarter, 3 analysts expect revenue to total $2.33M. It ranges from a high estimate of $2.8M to a low estimate of $2.1M. As of the current estimate, T2 Biosystems Inc.’s year-ago sales were $7.23M, an estimated decrease of -67.80% from the year-ago figure. For the next quarter, 3 analysts are estimating revenue of $2.57M, a decrease of -56.50% over than the figure of -$67.80% in the same quarter last year. There is a high estimate of $2.8M for the next quarter, whereas the lowest estimate is $2.4M.
A total of 3 analysts have provided revenue estimates for TTOO’s current fiscal year. The highest revenue estimate was $17.2M, while the lowest revenue estimate was $11.5M, resulting in an average revenue estimate of $13.73M. In the same quarter a year ago, actual revenue was $22.3M, down -38.40% from the average estimate. Based on 3 analysts’ estimates, the company’s revenue will be $25.53M in the next fiscal year. The high estimate is $31.8M and the low estimate is $17M. The average revenue growth estimate for next year is up 85.90% from the average revenue estimate for this year.
